Mont-Saint-Guibert, Belgium - Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the development of regenerative therapies, announces its participation in the 18th edition of the ODDO forum, dedicated to European Midcaps, that will take place on 8 and 9 January 2015 in Lyon. The ODDO Midcap forum is renowned as the largest event dedicated to European listed companies.

This event will enable Cardio3 BioSciences to highlight its on-going development programs and strategic vision for the future to potential investors.

Patrick Jeanmart, CFO of Cardio3 BioSciences, commented: “The ODDO Midcap forum is an excellent opportunity to increase Cardio3 Biosciences’ visibility towards European investors, but most importantly it is a unique occasion to present Cardio3 Biosciences’ development potential, positioning and strategic vision.”

Download press release(s)

Communiqué de presse

645.85 Ko

Press release

529.50 Ko

Cardio3 BioSciences announces the enrolment of the 240th patient for its CHART-1 phase III...

Next News

Cardio3 BioSciences announces the enrolment of the 240th patient for its CHART-1 phase III...